Latest News for: drug delivery
Edit
Pharmaceutical Drug Delivery Markets and Competition Forecast 2026-2032 with Global, Regional and Country-Level Analysis
Nasdaq Globe Newswire 23 Feb 2026
Edit
Accelerating next generation medicine with new drug delivery platform
Phys Dot Org 23 Feb 2026
Experts from the University of Nottingham's School of Pharmacy have created a new drug delivery platform ...
Edit
US Pharmaceutical Drug Delivery Market to Reach $1.24 Billion by 2031 as Biologics and Home-Based ...
GetNews 20 Feb 2026
US Pharmaceutical Drug Delivery Market by Route of Administration , Application (Cancer, Diabetes), Care Setting - Forecast to 2031 ... Prominent players operating in the US pharmaceutical drug delivery market include.
Edit
Hastings Tribune
19 Feb 2026
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and
Hastings Tribune
19 Feb 2026
AUSTIN, Texas, Feb.
Edit
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
Nasdaq Globe Newswire 19 Feb 2026
Edit
BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis (BioNxt Solutions Inc)
Public Technologies 17 Feb 2026
Feb 17, 2026 in News BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis ... Protecting a Patient-Focused, Needle-Free Drug Delivery Platform.
Edit
BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology ...
ACCESSWIRE 17 Feb 2026
("BioNxt" or the "Company") (CSE.BNXT)(OTCQB.BNXTF)(FSE.BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that the European Patent Office (EPO) has issued a Decision to Grant European Patent No.
Edit
BioNxt Receives Milestone EPO Decision to Grant European Patent for Sublingual Cladribine Drug Delivery Technology for Multiple Sclerosis
Pharmiweb 17 Feb 2026
("BioNxt" or the "Company") (CSE.BNXT)(OTCQB.BNXTF)(FSE.BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that the European Patent Office (EPO) has issued a Decision to Grant European Patent No.
Edit
Middle East & Africa Injectable Drug Delivery Market worth $22.54 billion by 2031 (Markets and Markets Limited)
Public Technologies 16 Feb 2026
) HOME Middle East & Africa Injectable Drug Delivery Market PDF Download. Middle East & Africa Injectable Drug Delivery by Product ...
Edit
Europe Injectable Drug Delivery Market worth $259.49 billion by 2031 (Markets and Markets Limited)
Public Technologies 16 Feb 2026
) HOME Europe Injectable Drug Delivery Market PDF Download. Europe Injectable Drug Delivery by Product (Device, Self Injection, Formulation, ...
Edit
US Injectable Drug Delivery Market to Reach $465.15 Billion by 2031
GetNews 14 Feb 2026
US Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) - Forecast to 2031.
Edit
‘Squeaky clean’ Louth farmer found guilty after gardaí staged €1.6m drugs delivery to his yard
Irish Independent 12 Feb 2026
... drugs seizure at his yard in Co.
Edit
Drug Delivery Companies Compendium Report 2026: A Cost-effective, Time-saving Directory That Answers All of Your ...
Nasdaq Globe Newswire 10 Feb 2026
Edit
Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform
Business Wire 10 Feb 2026
... to support the continued development of Callavid®, a novel platform for intravaginal drug delivery.
- 1
- 2
- Next page »